Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

This article was originally published in The Pink Sheet Daily

Executive Summary

Janssen subsidiary pleads guilty as part of $2.2 billion deal that also requires audits of sales rep compensation.

You may also be interested in...



AmerisourceBergen Settlement On Injectable Drug Repackaging Includes Forfeiture Of Exec Pay

Corporate integrity agreement attached to second DOJ settlement over repackaging of injectable cancer drugs would require recoupment of exec performance pay following misconduct.

Pharma Deals With The DOJ

A look at the settlement agreements pharma companies have struck with the Department of Justice in the last three years; the size of the deals has declined dramatically since 2012.

J&J Challenges Risperdal Penalty As First Amendment Violation

In case that could impact use of state unfair trade practices statutes, Janssen seeks Supreme Court review of South Carolina’s $124 million judgment for Risperdal labeling and Dear Doctor letter.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS075108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel